On Monday, biotech startup, TAXA Biotechnologies, Inc., made history by being one of the first to use Title III rules of the JOBS Act. The company launched its initial on equity crowdfunding platform, WeFunder. Founded in 2013, TAXA Biotechnologies consists of biologists and experts who use synthetic biology technologies… Read More
Caps off to Title III! As promised, WeFunder understood the potential of Reg CF and its opportunities for capital formation and entrepreneurship. Operating an accredited crowdfunding platform since the fall of 2013 and then adding Reg A+ last year, Wefunder has helped fund 110 companies with over… Read More
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.Ok
